Tag: common warts market share

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Market Value Expansion Is Expected For The Common Warts Market Over The Forecast Period?

The common warts market has seen substantial growth recently. It is projected to expand from $2.25 billion in 2025 to $2.38 billion in 2026, driven by a compound annual growth rate (CAGR) of 5.8%. This historical growth can be attributed to factors such as the increasing prevalence of hpv infections, widespread use of cryotherapy treatments, the availability of topical salicylic acid products, the growth of dermatology clinics, and improved awareness of skin health.

The common warts market is anticipated to show considerable expansion over the next few years. It is projected to achieve a size of $2.96 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 5.6%. This growth during the forecast period is fueled by an increasing demand for non-invasive dermatological procedures, a heightened focus on cosmetic dermatology solutions, the wider availability of homecare dermatology products, the growing adoption of laser-based therapies, and increased investment in immunomodulatory treatments. Key trends for the forecast period include advancements in minimally invasive wart removal techniques, a rising preference for combination therapy approaches, enhanced access to over-the-counter treatments, the expanding use of immunotherapy-based topicals, and an increase in home-based treatment options.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=21154&type=smp

What Market Drivers Are Helping Shape The Common Warts Market Expansion?

The common warts market is anticipated to expand due to the rising occurrence of viral infections. These infections are ailments resulting from viruses entering, replicating, and disseminating throughout the body, impacting cells and the immune system. Several factors contribute to the escalating prevalence of viral infections, including globalization, climate change, urbanization, deforestation, and compromised immune systems. Treatment for common warts focuses on the human papillomavirus (HPV), which causes wart development, offering crucial aid to patients with viral infections. This assistance involves curbing viral transmission, easing pain, and fostering recovery, thereby averting complications like secondary infections or scarring, and ultimately enhancing patients’ quality of life. For example, as reported by the US-based government agency, Centers for Disease Control and Prevention, in 2024, the percentage of PCR-confirmed varicella cases in 2022 increased by 62%, rising from 29% to 47% within the preceding five years. Additionally, in January 2023, the US-based health organization, National Foundation for Infectious Diseases, estimated that approximately 14 million new HPV infections occur each year in the United States. Consequently, the escalating occurrence of viral infections is stimulating expansion in the common warts market.

How Are Different Segment Groups Identified Within The Common Warts Market?

The common warts market covered in this report is segmented –

1) By Treatment Method: Cryotherapy, Laser Treatment, Electrosurgery, Topical Medications

2) By Patient Demographics: Children, Adults, Elderly

3) By Disease Stage: Initial Stage, Moderate Stage, Severe Stage

4) By End User: Hospitals, Dermatology Clinics, Home Care

Subsegments:

1) By Cryotherapy: Liquid Nitrogen Therapy, Carbon Dioxide Therapy

2) By Laser Treatment: Pulsed-Dye Laser Therapy, Carbon Dioxide (CO2) Laser Therapy

3) By Electrosurgery: Curettage And Electrosurgical Removal, High-Frequency Electrosurgical Ablation

4) By Topical Medications: Salicylic Acid-Based Therapy, Immunotherapy-Based Topicals, Retinoid-Based Therapy

Which Trends Are Expected To Shape The Common Warts Market?

Major companies operating in the common warts market are concentrating on advancing innovative treatments, particularly dermatological therapies, to address the escalating demand for effective and readily available solutions. This strategic focus aims to enhance patient outcomes and expand their market presence within the dermatology sector. Dermatological therapies refer to medical interventions for various skin conditions, including infections, inflammations, and other disorders. For instance, in May 2024, Verrica Pharmaceuticals, a US-based pharmaceutical company, established a license agreement with Torii Pharmaceutical Co. Ltd., a Japan-based pharmaceutical company. This collaboration is set to fund a global Phase 3 clinical trial for YCANTH, a treatment specifically for common warts. The agreement supports the late-stage development of YCANTH, thereby broadening its potential global reach. Torii Pharmaceuticals will contribute financial resources to advance this study, and the partnership strengthens both companies’ dermatology portfolios and their international market presence.

Which Companies Form The Competitive Landscape Of The Common Warts Market?

Major companies operating in the common warts market are GSK plc, Perrigo Company plc, Holland & Barrett International Limited, Prestige Consumer Healthcare Inc., Novan Inc., Aclaris Therapeutics Inc., Verrica Pharmaceuticals Inc., Scholl’s Wellness Company, Naturasil, Bausch Health Companies Inc., Viatris Inc., Sanofi S.A., Pfizer Inc., Bayer AG, Novartis AG, Dr Reddy’s Laboratories Ltd, Cipla Inc, Taro Pharmaceutical Industries Ltd, Teva Pharmaceutical Industries Ltd, AIM ImmunoTech Inc, Phio Pharmaceuticals Corp, Euro Vital Pharma GmbH, Koninklijke Utermöhlen NV, Lumenis Be Ltd, Almirall S.A, Daiichi Sankyo Company Ltd

Access The Complete Common Warts Market Report:

https://www.thebusinessresearchcompany.com/report/common-warts-global-market-report

Which Region Stands As The Largest Contributor To The Common Warts Market?

North America was the largest region in the common warts market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the common warts market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Common Warts Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/customise?id=21154&type=smp

Browse Through More Reports Similar to the Global Common Warts Market 2026, By The Business Research Company

Chronic Cough Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/chronic-cough-global-market-report

Cold Pain Therapy Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/cold-pain-therapy-global-market-report

Cold Plasma Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/cold-plasma-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Is The Market Size Of The Common Warts Market Expected To Scale Between 2026 And 2030?

The common warts market size has experienced robust growth in recent years. It is anticipated to expand from $2.25 billion in 2025 to $2.38 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 5.8%. This historical growth can be linked to the increasing prevalence of hpv infections, widespread use of cryotherapy treatments, availability of topical salicylic acid products, growth of dermatology clinics, and improved awareness of skin health.

The common warts market is anticipated to experience robust expansion over the forthcoming years. It is projected to attain a valuation of $2.96 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 5.6%. This expected growth during the forecast period is driven by factors such as the increasing demand for non-invasive dermatological treatments, a rising emphasis on cosmetic dermatology solutions, the widening array of homecare dermatology products, the growing uptake of laser-based therapies, and enhanced investment in immunomodulatory treatments. Noteworthy trends predicted for this period encompass advancements in minimally invasive wart removal techniques, a rising embrace of combination therapy approaches, greater availability of over-the-counter treatments, the expanding utilization of immunotherapy-based topical applications, and an increase in home-based treatment options.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/report/common-warts-global-market-report

What Major Factors Are Driving The Common Warts Market Forward?

The common warts market is anticipated to expand due to the rising occurrence of viral infections. Viral infections are diseases that occur when viruses infiltrate, reproduce, and disseminate throughout the body, impacting cells and immune system functions. Factors such as globalization, climate change, urbanization, deforestation, and compromised immune systems contribute to this growing prevalence of viral infections. Treatment for common warts focuses on the human papillomavirus (HPV) that causes them, offering crucial assistance to individuals with viral infections by limiting viral transmission, easing pain, encouraging recovery, and thereby averting issues like secondary infections or scarring, ultimately enhancing patients’ quality of life. For example, data from the US-based government agency, the Centers for Disease Control and Prevention, indicates that in 2024, the percentage of PCR-confirmed varicella cases in 2022 climbed by 62%, moving from 29% to 47% in the previous five years. Additionally, the US-based health organization, the National Foundation for Infectious Diseases, reported in January 2023 that approximately 14 million new HPV infections are diagnosed each year in the United States. Consequently, the expanding occurrence of viral infections is fueling the expansion of the common warts market.

How Is Segmentation Applied In The Common Warts Market Segment Analysis?

The common warts market covered in this report is segmented –

1) By Treatment Method: Cryotherapy, Laser Treatment, Electrosurgery, Topical Medications

2) By Patient Demographics: Children, Adults, Elderly

3) By Disease Stage: Initial Stage, Moderate Stage, Severe Stage

4) By End User: Hospitals, Dermatology Clinics, Home Care

Subsegments:

1) By Cryotherapy: Liquid Nitrogen Therapy, Carbon Dioxide Therapy

2) By Laser Treatment: Pulsed-Dye Laser Therapy, Carbon Dioxide (CO2) Laser Therapy

3) By Electrosurgery: Curettage And Electrosurgical Removal, High-Frequency Electrosurgical Ablation

4) By Topical Medications: Salicylic Acid-Based Therapy, Immunotherapy-Based Topicals, Retinoid-Based Therapy

Which Trends Are Impacting The Progress Of The Common Warts Market?

Leading entities within the common warts market are prioritizing the advancement of innovative treatments, such as dermatological therapies, to address the increasing demand for effective and accessible solutions. This focus aims to enhance patient outcomes and broaden their footprint within the dermatology sector. Dermatological therapies involve treatments for various skin conditions, including infections, inflammations, and disorders. For example, in May 2024, Verrica Pharmaceuticals, a US-based pharmaceutical company, formed a license agreement with Torii Pharmaceutical Co. Ltd., a Japan-based pharmaceutical company. This collaboration is designed to fund a global Phase 3 clinical trial for YCANTH, a treatment specifically for common warts. The agreement provides support for the late-stage development of YCANTH, thereby expanding its potential reach worldwide. Torii Pharmaceuticals is committed to contributing financial resources to further this study. This joint effort is expected to bolster the dermatology portfolios and international market presence for both companies.

Who Are The Companies Participating In The Common Warts Market Environment?

Major companies operating in the common warts market are GSK plc, Perrigo Company plc, Holland & Barrett International Limited, Prestige Consumer Healthcare Inc., Novan Inc., Aclaris Therapeutics Inc., Verrica Pharmaceuticals Inc., Scholl’s Wellness Company, Naturasil, Bausch Health Companies Inc., Viatris Inc., Sanofi S.A., Pfizer Inc., Bayer AG, Novartis AG, Dr Reddy’s Laboratories Ltd, Cipla Inc, Taro Pharmaceutical Industries Ltd, Teva Pharmaceutical Industries Ltd, AIM ImmunoTech Inc, Phio Pharmaceuticals Corp, Euro Vital Pharma GmbH, Koninklijke Utermöhlen NV, Lumenis Be Ltd, Almirall S.A, Daiichi Sankyo Company Ltd

Get The Full Common Warts Market Report:

https://www.thebusinessresearchcompany.com/report/common-warts-global-market-report

Which Region Is The Leading Market For The Common Warts Market?

North America was the largest region in the common warts market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the common warts market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Common Warts Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/common-warts-global-market-report

Browse Through More Reports Similar to the Global Common Warts Market 2026, By The Business Research Company

Specialty Malt Market Report 2026

https://www.thebusinessresearchcompany.com/report/specialty-malt-global-market-report

Warts Therapeutics Market Report 2026

https://www.thebusinessresearchcompany.com/report/warts-therapeutics-global-market-report

Asphalt Shingles Market Report 2026

https://www.thebusinessresearchcompany.com/report/asphalt-shingles-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Is The Market Size Of The Common Warts Market Expected To Scale Between 2026 And 2030?

The common warts market size has experienced robust growth in recent years. It is anticipated to expand from $2.25 billion in 2025 to $2.38 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 5.8%. This historical growth can be linked to the increasing prevalence of hpv infections, widespread use of cryotherapy treatments, availability of topical salicylic acid products, growth of dermatology clinics, and improved awareness of skin health.

The common warts market is anticipated to experience robust expansion over the forthcoming years. It is projected to attain a valuation of $2.96 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 5.6%. This expected growth during the forecast period is driven by factors such as the increasing demand for non-invasive dermatological treatments, a rising emphasis on cosmetic dermatology solutions, the widening array of homecare dermatology products, the growing uptake of laser-based therapies, and enhanced investment in immunomodulatory treatments. Noteworthy trends predicted for this period encompass advancements in minimally invasive wart removal techniques, a rising embrace of combination therapy approaches, greater availability of over-the-counter treatments, the expanding utilization of immunotherapy-based topical applications, and an increase in home-based treatment options.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/report/common-warts-global-market-report

What Major Factors Are Driving The Common Warts Market Forward?

The common warts market is anticipated to expand due to the rising occurrence of viral infections. Viral infections are diseases that occur when viruses infiltrate, reproduce, and disseminate throughout the body, impacting cells and immune system functions. Factors such as globalization, climate change, urbanization, deforestation, and compromised immune systems contribute to this growing prevalence of viral infections. Treatment for common warts focuses on the human papillomavirus (HPV) that causes them, offering crucial assistance to individuals with viral infections by limiting viral transmission, easing pain, encouraging recovery, and thereby averting issues like secondary infections or scarring, ultimately enhancing patients’ quality of life. For example, data from the US-based government agency, the Centers for Disease Control and Prevention, indicates that in 2024, the percentage of PCR-confirmed varicella cases in 2022 climbed by 62%, moving from 29% to 47% in the previous five years. Additionally, the US-based health organization, the National Foundation for Infectious Diseases, reported in January 2023 that approximately 14 million new HPV infections are diagnosed each year in the United States. Consequently, the expanding occurrence of viral infections is fueling the expansion of the common warts market.

How Is Segmentation Applied In The Common Warts Market Segment Analysis?

The common warts market covered in this report is segmented –

1) By Treatment Method: Cryotherapy, Laser Treatment, Electrosurgery, Topical Medications

2) By Patient Demographics: Children, Adults, Elderly

3) By Disease Stage: Initial Stage, Moderate Stage, Severe Stage

4) By End User: Hospitals, Dermatology Clinics, Home Care

Subsegments:

1) By Cryotherapy: Liquid Nitrogen Therapy, Carbon Dioxide Therapy

2) By Laser Treatment: Pulsed-Dye Laser Therapy, Carbon Dioxide (CO2) Laser Therapy

3) By Electrosurgery: Curettage And Electrosurgical Removal, High-Frequency Electrosurgical Ablation

4) By Topical Medications: Salicylic Acid-Based Therapy, Immunotherapy-Based Topicals, Retinoid-Based Therapy

Which Trends Are Impacting The Progress Of The Common Warts Market?

Leading entities within the common warts market are prioritizing the advancement of innovative treatments, such as dermatological therapies, to address the increasing demand for effective and accessible solutions. This focus aims to enhance patient outcomes and broaden their footprint within the dermatology sector. Dermatological therapies involve treatments for various skin conditions, including infections, inflammations, and disorders. For example, in May 2024, Verrica Pharmaceuticals, a US-based pharmaceutical company, formed a license agreement with Torii Pharmaceutical Co. Ltd., a Japan-based pharmaceutical company. This collaboration is designed to fund a global Phase 3 clinical trial for YCANTH, a treatment specifically for common warts. The agreement provides support for the late-stage development of YCANTH, thereby expanding its potential reach worldwide. Torii Pharmaceuticals is committed to contributing financial resources to further this study. This joint effort is expected to bolster the dermatology portfolios and international market presence for both companies.

Who Are The Companies Participating In The Common Warts Market Environment?

Major companies operating in the common warts market are GSK plc, Perrigo Company plc, Holland & Barrett International Limited, Prestige Consumer Healthcare Inc., Novan Inc., Aclaris Therapeutics Inc., Verrica Pharmaceuticals Inc., Scholl’s Wellness Company, Naturasil, Bausch Health Companies Inc., Viatris Inc., Sanofi S.A., Pfizer Inc., Bayer AG, Novartis AG, Dr Reddy’s Laboratories Ltd, Cipla Inc, Taro Pharmaceutical Industries Ltd, Teva Pharmaceutical Industries Ltd, AIM ImmunoTech Inc, Phio Pharmaceuticals Corp, Euro Vital Pharma GmbH, Koninklijke Utermöhlen NV, Lumenis Be Ltd, Almirall S.A, Daiichi Sankyo Company Ltd

Get The Full Common Warts Market Report:

https://www.thebusinessresearchcompany.com/report/common-warts-global-market-report

Which Region Is The Leading Market For The Common Warts Market?

North America was the largest region in the common warts market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the common warts market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Common Warts Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/common-warts-global-market-report

Browse Through More Reports Similar to the Global Common Warts Market 2026, By The Business Research Company

Specialty Malt Market Report 2026

https://www.thebusinessresearchcompany.com/report/specialty-malt-global-market-report

Warts Therapeutics Market Report 2026

https://www.thebusinessresearchcompany.com/report/warts-therapeutics-global-market-report

Asphalt Shingles Market Report 2026

https://www.thebusinessresearchcompany.com/report/asphalt-shingles-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Is The Market Size Of The Common Warts Market Expected To Scale Between 2026 And 2030?

The common warts market size has experienced robust growth in recent years. It is anticipated to expand from $2.25 billion in 2025 to $2.38 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 5.8%. This historical growth can be linked to the increasing prevalence of hpv infections, widespread use of cryotherapy treatments, availability of topical salicylic acid products, growth of dermatology clinics, and improved awareness of skin health.

The common warts market is anticipated to experience robust expansion over the forthcoming years. It is projected to attain a valuation of $2.96 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 5.6%. This expected growth during the forecast period is driven by factors such as the increasing demand for non-invasive dermatological treatments, a rising emphasis on cosmetic dermatology solutions, the widening array of homecare dermatology products, the growing uptake of laser-based therapies, and enhanced investment in immunomodulatory treatments. Noteworthy trends predicted for this period encompass advancements in minimally invasive wart removal techniques, a rising embrace of combination therapy approaches, greater availability of over-the-counter treatments, the expanding utilization of immunotherapy-based topical applications, and an increase in home-based treatment options.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/report/common-warts-global-market-report

What Major Factors Are Driving The Common Warts Market Forward?

The common warts market is anticipated to expand due to the rising occurrence of viral infections. Viral infections are diseases that occur when viruses infiltrate, reproduce, and disseminate throughout the body, impacting cells and immune system functions. Factors such as globalization, climate change, urbanization, deforestation, and compromised immune systems contribute to this growing prevalence of viral infections. Treatment for common warts focuses on the human papillomavirus (HPV) that causes them, offering crucial assistance to individuals with viral infections by limiting viral transmission, easing pain, encouraging recovery, and thereby averting issues like secondary infections or scarring, ultimately enhancing patients’ quality of life. For example, data from the US-based government agency, the Centers for Disease Control and Prevention, indicates that in 2024, the percentage of PCR-confirmed varicella cases in 2022 climbed by 62%, moving from 29% to 47% in the previous five years. Additionally, the US-based health organization, the National Foundation for Infectious Diseases, reported in January 2023 that approximately 14 million new HPV infections are diagnosed each year in the United States. Consequently, the expanding occurrence of viral infections is fueling the expansion of the common warts market.

How Is Segmentation Applied In The Common Warts Market Segment Analysis?

The common warts market covered in this report is segmented –

1) By Treatment Method: Cryotherapy, Laser Treatment, Electrosurgery, Topical Medications

2) By Patient Demographics: Children, Adults, Elderly

3) By Disease Stage: Initial Stage, Moderate Stage, Severe Stage

4) By End User: Hospitals, Dermatology Clinics, Home Care

Subsegments:

1) By Cryotherapy: Liquid Nitrogen Therapy, Carbon Dioxide Therapy

2) By Laser Treatment: Pulsed-Dye Laser Therapy, Carbon Dioxide (CO2) Laser Therapy

3) By Electrosurgery: Curettage And Electrosurgical Removal, High-Frequency Electrosurgical Ablation

4) By Topical Medications: Salicylic Acid-Based Therapy, Immunotherapy-Based Topicals, Retinoid-Based Therapy

Which Trends Are Impacting The Progress Of The Common Warts Market?

Leading entities within the common warts market are prioritizing the advancement of innovative treatments, such as dermatological therapies, to address the increasing demand for effective and accessible solutions. This focus aims to enhance patient outcomes and broaden their footprint within the dermatology sector. Dermatological therapies involve treatments for various skin conditions, including infections, inflammations, and disorders. For example, in May 2024, Verrica Pharmaceuticals, a US-based pharmaceutical company, formed a license agreement with Torii Pharmaceutical Co. Ltd., a Japan-based pharmaceutical company. This collaboration is designed to fund a global Phase 3 clinical trial for YCANTH, a treatment specifically for common warts. The agreement provides support for the late-stage development of YCANTH, thereby expanding its potential reach worldwide. Torii Pharmaceuticals is committed to contributing financial resources to further this study. This joint effort is expected to bolster the dermatology portfolios and international market presence for both companies.

Who Are The Companies Participating In The Common Warts Market Environment?

Major companies operating in the common warts market are GSK plc, Perrigo Company plc, Holland & Barrett International Limited, Prestige Consumer Healthcare Inc., Novan Inc., Aclaris Therapeutics Inc., Verrica Pharmaceuticals Inc., Scholl’s Wellness Company, Naturasil, Bausch Health Companies Inc., Viatris Inc., Sanofi S.A., Pfizer Inc., Bayer AG, Novartis AG, Dr Reddy’s Laboratories Ltd, Cipla Inc, Taro Pharmaceutical Industries Ltd, Teva Pharmaceutical Industries Ltd, AIM ImmunoTech Inc, Phio Pharmaceuticals Corp, Euro Vital Pharma GmbH, Koninklijke Utermöhlen NV, Lumenis Be Ltd, Almirall S.A, Daiichi Sankyo Company Ltd

Get The Full Common Warts Market Report:

https://www.thebusinessresearchcompany.com/report/common-warts-global-market-report

Which Region Is The Leading Market For The Common Warts Market?

North America was the largest region in the common warts market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the common warts market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Common Warts Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/common-warts-global-market-report

Browse Through More Reports Similar to the Global Common Warts Market 2026, By The Business Research Company

Specialty Malt Market Report 2026

https://www.thebusinessresearchcompany.com/report/specialty-malt-global-market-report

Warts Therapeutics Market Report 2026

https://www.thebusinessresearchcompany.com/report/warts-therapeutics-global-market-report

Asphalt Shingles Market Report 2026

https://www.thebusinessresearchcompany.com/report/asphalt-shingles-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Will Be The Estimated Market Valuation Of The Common Warts Market By The End Of 2030?

The common warts market size has experienced robust growth in recent years. This market is anticipated to expand from $2.25 billion in 2025 to $2.38 billion in 2026, driven by a compound annual growth rate (CAGR) of 5.8%. Factors contributing to this historical growth include the increasing prevalence of hpv infections, widespread use of cryotherapy treatments, availability of topical salicylic acid products, expansion of dermatology clinics, and heightened awareness of skin health.

The common warts market is anticipated to demonstrate significant expansion in the foreseeable future, with projections indicating it will reach $2.96 billion by 2030, expanding at a compound annual growth rate (CAGR) of 5.6%. This rise during the forecast period is fueled by several factors, including the increasing desire for non-invasive dermatological solutions, a heightened interest in cosmetic dermatology, the growth of homecare dermatology products, the rising acceptance of laser-based treatments, and increased financial input into immunomodulatory therapies. Notable developments expected in this period encompass improvements in minimally invasive wart removal techniques, an increase in the application of combination therapy strategies, wider availability of over-the-counter treatments, an expanding use of immunotherapy-based topical applications, and the proliferation of home-based treatment choices.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=21154&type=smp

What Primary Drivers Are Shaping The Development Of The Common Warts Market?

The common warts market is projected for growth due to the escalating occurrence of viral infections. Viral infections are defined as illnesses caused by viruses entering, multiplying, and spreading within the body, impacting cells and immune responses. The rising frequency of viral infections is influenced by globalization, climate change, urbanization, deforestation, and compromised immune responses. Treatment for common warts targets the human papillomavirus (HPV) responsible for their formation, offering crucial support to viral infection patients by reducing viral spread, alleviating discomfort, and promoting healing, thereby preventing complications like secondary infections or scarring while enhancing the patient’s quality of life. For instance, in 2024, the Centers for Disease Control and Prevention, a US-based government agency, reported that in 2022, the proportion of PCR-confirmed varicella cases increased by 62%, growing from 29% to 47% over the past five years. Furthermore, in January 2023, according to the National Foundation for Infectious Diseases, a US-based health organization, an estimated 14 million new cases of HPV infection occur annually in the United States. Therefore, the increasing incidence of viral infections is driving expansion in the common warts market.

Which Segment Classifications Shape The Common Warts Market?

The common warts market covered in this report is segmented –

1) By Treatment Method: Cryotherapy, Laser Treatment, Electrosurgery, Topical Medications

2) By Patient Demographics: Children, Adults, Elderly

3) By Disease Stage: Initial Stage, Moderate Stage, Severe Stage

4) By End User: Hospitals, Dermatology Clinics, Home Care

Subsegments:

1) By Cryotherapy: Liquid Nitrogen Therapy, Carbon Dioxide Therapy

2) By Laser Treatment: Pulsed-Dye Laser Therapy, Carbon Dioxide (CO2) Laser Therapy

3) By Electrosurgery: Curettage And Electrosurgical Removal, High-Frequency Electrosurgical Ablation

4) By Topical Medications: Salicylic Acid-Based Therapy, Immunotherapy-Based Topicals, Retinoid-Based Therapy

What Major Market Trends Are Driving Changes In The Common Warts Market?

Leading firms in the common warts market are prioritizing the development of innovative treatments, including dermatological therapies, in response to the increasing need for effective and readily available solutions, with the goal of enhancing patient results and broadening their footprint in dermatology. These therapies address various skin conditions, such as infections, inflammations, and other disorders. An example of this is the license agreement established in May 2024 between Verrica Pharmaceuticals, a US-based pharmaceutical entity, and Torii Pharmaceutical Co. Ltd., a Japan-based pharmaceutical entity. This partnership is designed to finance a worldwide Phase 3 clinical trial for YCANTH, which treats common warts. The agreement facilitates the late-stage development of YCANTH, thereby extending its potential global accessibility. Torii Pharmaceuticals is set to provide financial backing to progress the study. This collaboration enhances the dermatology portfolios and international market presence of both companies.

Which Companies Are Expanding Their Footprint In The Common Warts Market?

Major companies operating in the common warts market are GSK plc, Perrigo Company plc, Holland & Barrett International Limited, Prestige Consumer Healthcare Inc., Novan Inc., Aclaris Therapeutics Inc., Verrica Pharmaceuticals Inc., Scholl’s Wellness Company, Naturasil, Bausch Health Companies Inc., Viatris Inc., Sanofi S.A., Pfizer Inc., Bayer AG, Novartis AG, Dr Reddy’s Laboratories Ltd, Cipla Inc, Taro Pharmaceutical Industries Ltd, Teva Pharmaceutical Industries Ltd, AIM ImmunoTech Inc, Phio Pharmaceuticals Corp, Euro Vital Pharma GmbH, Koninklijke Utermöhlen NV, Lumenis Be Ltd, Almirall S.A, Daiichi Sankyo Company Ltd

Read the full common warts market report here:

https://www.thebusinessresearchcompany.com/report/common-warts-global-market-report

How Does The Common Warts Market Perform Across Major Global Regions?

North America was the largest region in the common warts market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the common warts market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Common Warts Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=21154&type=smp

Browse Through More Reports Similar to the Global Common Warts Market 2026, By The Business Research Company

Chronic Cough Global Market Report

https://www.thebusinessresearchcompany.com/report/chronic-cough-global-market-report

Cold Pain Therapy Global Market Report

https://www.thebusinessresearchcompany.com/report/cold-pain-therapy-global-market-report

Cold Plasma Global Market Report

https://www.thebusinessresearchcompany.com/report/cold-plasma-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model